Fourteen variants were identified through molecular screening and raw DNA sequence analysis: 1 in BRAF, 11 in KRAS, and 2 in NRAS, including NRAS R102Q, previously unreported in CRC data. This evidence concerns the gene BRAF and colorectal carcinoma.